Metronidazole-induced encephalopathy in a patient with infectious colitis: a case report

Hoon Kim1, Young Woo Kim, Seoung Rim Kim

  • 1Department of Neurosurgery, Bucheon St Mary's Hospital, College of Medicine, Catholic University, Bucheon, Korea. jkw94@naver.com.

Abstract

Insights

Metronidazole can cause rare neurological side effects like encephalopathy and cerebellar syndrome. This case shows these effects are reversible after stopping the antibiotic, highlighting the need for careful monitoring.

Area of Science:

  • Neurology
  • Pharmacology
  • Radiology

Background:

  • Encephalopathy is a rare adverse effect of antibiotics like metronidazole.
  • Metronidazole neurotoxicity has been previously studied, but incidence is unknown.
  • This report details a case of reversible cerebellar dysfunction linked to metronidazole.

Purpose of the Study:

  • To report a case of metronidazole-induced encephalopathy.
  • To highlight the reversibility of metronidazole-induced neurological symptoms.
  • To emphasize the importance of considering metronidazole toxicity in patients with neurological disorders.

Main Methods:

  • Case presentation of a 71-year-old man with infectious colitis treated with metronidazole.
  • Clinical observation of drowsiness and slow response after metronidazole administration.
  • Brain MRI (T2-weighted and FLAIR) to assess neurological changes.

Main Results:

  • Patient developed drowsiness and slow response after metronidazole treatment.
  • MRI revealed bilateral symmetric hyperintensities in the dentate nucleus, cerebellum, and corpus callosum.
  • Discontinuation of metronidazole led to resolution of cerebellar syndrome and MRI signal changes.

Conclusions:

  • Metronidazole can cause neurological side effects, including cerebellar syndrome and encephalopathy.
  • Metronidazole-induced encephalopathy is reversible upon drug cessation.
  • Clinicians should consider metronidazole toxicity in patients with new-onset neurological symptoms.

Related Concept Videos

Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...